SetPoint Medical Delivers First FDA-Approved RA Device in N.C.
VALENCIA, Calif., June 29, 2026 SetPoint Medical has announced a significant milestone in the expansion of its FDA-approved SetPoint...
rheumatoid arthritis
Advertisement
Rise Therapeutics Completes Enrollment in R-2487 Rheumatoid Arthritis Trial
ROCKVILLE, Maryland, June 2, 2026 Rise Therapeutics announced the completion of full enrollment in the four-week dose expansion cohort...
Jade Biosciences Doses First Patient With JADE201
SAN FRANCISCO and VANCOUVER, British Columbia, May 26, 2026 Jade Biosciences announced the first participant has been dosed in...
Artiva Biotherapeutics Showcases AlloNK Data at EULAR 2026
SAN DIEGO, California, May 19, 2026 Artiva Biotherapeutics announced multiple data presentations at the upcoming EULAR 2026 Congress highlighting...
Zymeworks Launches $125M Share Repurchase Program
VANCOUVER, British Columbia, May 14, 2026 Zymeworks Inc. announced that its Board of Directors has approved a new 2026...
Advertisements
SetPoint System Could Cut Lifetime RA Care Costs by $350,000
VALENCIA, Calif., May 14, 2026 SetPoint Medical announced the publication of a peer-reviewed health economics study demonstrating that its...
Lifordi Gains Major Investment to Advance ADC Autoimmune Therapy
Dateline Introduction Burlington, Massachusetts — November 18, 2025 — Lifordi Immunotherapeutics has announced a strategic investment from Sanofi Ventures,...
New 14-3-3η RA Test Expands Early Detection and Monitoring Options
Dateline IntroductionNovember 17, 2025 — Vancouver, BC & Austin, TX — Augurex Life Sciences Corp. announced the launch of...
Exagen Inc. Showcases Autoimmune Diagnostic Leadership at Q4 2025 Conferences
Dateline — CARLSBAD, Calif., November 11, 2025:Exagen Inc. (Nasdaq: XGN), a leader in autoimmune diagnostics, has announced its participation...
Advertisement
